Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Fournié GJ[au]:

VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis. Guerreiro-Cacais AO et al. Genes Immun. (2017)

VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis. Guerreiro-Cacais AO et al. Genes Immun. (2017)

ALOX12 in human toxoplasmosis. Witola WH et al. Infect Immun. (2014)

Search results

Items: 1 to 50 of 83

1.

VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis.

Guerreiro-Cacais AO, Norin U, Gyllenberg A, Berglund R, Beyeen AD; Rheumatoid Arthritis Consortium International (RACI), Petit-Teixeira E, Cornélis F, Saoudi A, Fournié GJ, Holmdahl R, Alfredsson L, Klareskog L, Jagodic M, Olsson T, Kockum I, Padyukov L.

Genes Immun. 2017 Mar;18(2):109. doi: 10.1038/gene.2017.7. No abstract available.

PMID:
28446790
2.

VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis.

Guerreiro-Cacais AO, Norin U, Gyllenberg A, Berglund R, Beyeen AD; Rheumatoid Arthritis Consortium International (RACI), Petit-Teixeira E, Cornélis F, Saoudi A, Fournié GJ, Holmdahl R, Alfredsson L, Klareskog L, Jagodic M, Olsson T, Kockum I, Padyukov L.

Genes Immun. 2017 Jan;18(1):48-56. doi: 10.1038/gene.2016.49. Epub 2017 Jan 5. Erratum in: Genes Immun. 2017 Mar;18(2):109.

PMID:
28053322
3.

A Natural Variant of the T Cell Receptor-Signaling Molecule Vav1 Reduces Both Effector T Cell Functions and Susceptibility to Neuroinflammation.

Kassem S, Gaud G, Bernard I, Benamar M, Dejean AS, Liblau R, Fournié GJ, Colacios C, Malissen B, Saoudi A.

PLoS Genet. 2016 Jul 20;12(7):e1006185. doi: 10.1371/journal.pgen.1006185. eCollection 2016 Jul.

4.

An Epistatic Interaction between Themis1 and Vav1 Modulates Regulatory T Cell Function and Inflammatory Bowel Disease Development.

Pedros C, Gaud G, Bernard I, Kassem S, Chabod M, Lagrange D, Andréoletti O, Dejean AS, Lesourne R, Fournié GJ, Saoudi A.

J Immunol. 2015 Aug 15;195(4):1608-16. doi: 10.4049/jimmunol.1402562. Epub 2015 Jul 10.

5.

A highly conserved Toxo1 haplotype directs resistance to toxoplasmosis and its associated caspase-1 dependent killing of parasite and host macrophage.

Cavailles P, Flori P, Papapietro O, Bisanz C, Lagrange D, Pilloux L, Massera C, Cristinelli S, Jublot D, Bastien O, Loeuillet C, Aldebert D, Touquet B, Fournié GJ, Cesbron-Delauw MF.

PLoS Pathog. 2014 Apr 3;10(4):e1004005. doi: 10.1371/journal.ppat.1004005. eCollection 2014 Apr.

6.

ALOX12 in human toxoplasmosis.

Witola WH, Liu SR, Montpetit A, Welti R, Hypolite M, Roth M, Zhou Y, Mui E, Cesbron-Delauw MF, Fournie GJ, Cavailles P, Bisanz C, Boyer K, Withers S, Noble AG, Swisher CN, Heydemann PT, Rabiah P, Muench SP, McLeod R.

Infect Immun. 2014 Jul;82(7):2670-9. doi: 10.1128/IAI.01505-13. Epub 2014 Mar 31.

7.

Hnf-1β transcription factor is an early hif-1α-independent marker of epithelial hypoxia and controls renal repair.

Faguer S, Mayeur N, Casemayou A, Pageaud AL, Courtellemont C, Cartery C, Fournie GJ, Schanstra JP, Tack I, Bascands JL, Chauveau D.

PLoS One. 2013 May 21;8(5):e63585. doi: 10.1371/journal.pone.0063585. Print 2013.

8.

Genetic control of HgCl2-induced IgE and autoimmunity by a 117-kb interval on rat chromosome 9 through CD4 CD45RChigh T cells.

Pedros C, Papapietro O, Colacios C, Casemayou A, Bernard I, Garcia V, Lagrange D, Mariamé B, Andreoletti O, Fournié GJ, Saoudi A.

Genes Immun. 2013 Jun;14(4):258-67. doi: 10.1038/gene.2013.21. Epub 2013 Apr 25.

PMID:
23615071
9.

A spontaneous mutation of the rat Themis gene leads to impaired function of regulatory T cells linked to inflammatory bowel disease.

Chabod M, Pedros C, Lamouroux L, Colacios C, Bernard I, Lagrange D, Balz-Hara D, Mosnier JF, Laboisse C, Vergnolle N, Andreoletti O, Roth MP, Liblau R, Fournié GJ, Saoudi A, Dejean AS.

PLoS Genet. 2012 Jan;8(1):e1002461. doi: 10.1371/journal.pgen.1002461. Epub 2012 Jan 19.

10.

Expression of renal cystic genes in patients with HNF1B mutations.

Faguer S, Decramer S, Devuyst O, Lengelé JP, Fournié GJ, Chauveau D.

Nephron Clin Pract. 2012;120(2):c71-8. doi: 10.1159/000334954. Epub 2012 Jan 21.

11.

The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell development.

Colacios C, Casemayou A, Dejean AS, Gaits-Iacovoni F, Pedros C, Bernard I, Lagrange D, Deckert M, Lamouroux L, Jagodic M, Olsson T, Liblau RS, Fournié GJ, Saoudi A.

J Exp Med. 2011 Oct 24;208(11):2183-91. doi: 10.1084/jem.20102191. Epub 2011 Sep 26.

12.

NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells.

Witola WH, Mui E, Hargrave A, Liu S, Hypolite M, Montpetit A, Cavailles P, Bisanz C, Cesbron-Delauw MF, Fournié GJ, McLeod R.

Infect Immun. 2011 Feb;79(2):756-66. doi: 10.1128/IAI.00898-10. Epub 2010 Nov 22.

13.

A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis.

Jagodic M, Colacios C, Nohra R, Dejean AS, Beyeen AD, Khademi M, Casemayou A, Lamouroux L, Duthoit C, Papapietro O, Sjöholm L, Bernard I, Lagrange D, Dahlman I, Lundmark F, Oturai AB, Soendergaard HB, Kemppinen A, Saarela J, Tienari PJ, Harbo HF, Spurkland A, Ramagopalan SV, Sadovnick DA, Ebers GC, Seddighzadeh M, Klareskog L, Alfredsson L, Padyukov L, Hillert J, Clanet M, Edan G, Fontaine B, Fournié GJ, Kockum I, Saoudi A, Olsson T.

Sci Transl Med. 2009 Dec 9;1(10):10ra21. doi: 10.1126/scitranslmed.3000278.

14.

Genomics studies of immune-mediated diseases using the BN-LEW rat model.

Bernard I, Fournié GJ, Saoudi A.

Methods Mol Biol. 2010;597:389-402. doi: 10.1007/978-1-60327-389-3_26. Review.

PMID:
20013247
15.

Generation of congenic and consomic rat strains.

Lagrange D, Fournié GJ.

Methods Mol Biol. 2010;597:243-66. doi: 10.1007/978-1-60327-389-3_17.

PMID:
20013238
16.

[The rat Toxo1 locus controls the outcome of the toxoplasmic infection according to a mendelian mode].

Cavaillès P, Bisanz C, Papapietro O, Colacios C, Sergent V, Pipy B, Saoudi A, Cesbron-Delauw MF, Fournié GJ.

Med Sci (Paris). 2006 Aug-Sep;22(8-9):679-80. French. No abstract available.

17.

The Th2 lymphoproliferation developing in LatY136F mutant mice triggers polyclonal B cell activation and systemic autoimmunity.

Genton C, Wang Y, Izui S, Malissen B, Delsol G, Fournié GJ, Malissen M, Acha-Orbea H.

J Immunol. 2006 Aug 15;177(4):2285-93.

18.

The rat Toxo1 locus directs toxoplasmosis outcome and controls parasite proliferation and spreading by macrophage-dependent mechanisms.

Cavaillès P, Sergent V, Bisanz C, Papapietro O, Colacios C, Mas M, Subra JF, Lagrange D, Calise M, Appolinaire S, Faraut T, Druet P, Saoudi A, Bessieres MH, Pipy B, Cesbron-Delauw MF, Fournié GJ.

Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):744-9. Epub 2006 Jan 6.

19.

Innate refractoriness of the Lewis rat to toxoplasmosis is a dominant trait that is intrinsic to bone marrow-derived cells.

Sergent V, Cautain B, Khalife J, Deslée D, Bastien P, Dao A, Dubremetz JF, Fournié GJ, Saoudi A, Cesbron-Delauw MF.

Infect Immun. 2005 Oct;73(10):6990-7.

20.

Functional and genetic analysis of two CD8 T cell subsets defined by the level of CD45RC expression in the rat.

Xystrakis E, Cavailles P, Dejean AS, Cautain B, Colacios C, Lagrange D, van de Gaar MJ, Bernard I, Gonzalez-Dunia D, Damoiseaux J, Fournié GJ, Saoudi A.

J Immunol. 2004 Sep 1;173(5):3140-7.

21.
22.

Dihydropyridine receptors are selective markers of Th2 cells and can be targeted to prevent Th2-dependent immunopathological disorders.

Savignac M, Gomes B, Gallard A, Narbonnet S, Moreau M, Leclerc C, Paulet P, Mariamé B, Druet P, Saoudi A, Fournié GJ, Guéry JC, Pelletier L.

J Immunol. 2004 May 1;172(9):5206-12.

23.
24.

Cellular and genetic factors involved in the difference between Brown Norway and Lewis rats to develop respectively type-2 and type-1 immune-mediated diseases.

Fournié GJ, Cautain B, Xystrakis E, Damoiseaux J, Mas M, Lagrange D, Bernard I, Subra JF, Pelletier L, Druet P, Saoudi A.

Immunol Rev. 2001 Dec;184:145-60. Review.

PMID:
12086309
25.

Induction of autoimmunity through bystander effects. Lessons from immunological disorders induced by heavy metals.

Fournié GJ, Mas M, Cautain B, Savignac M, Subra JF, Pelletier L, Saoudi A, Lagrange D, Calise M, Druet P.

J Autoimmun. 2001 May;16(3):319-26. Review.

PMID:
11334498
26.

The balance between CD45RChigh and CD45RClow CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled.

Subra JF, Cautain B, Xystrakis E, Mas M, Lagrange D, van der Heijden H, van de Gaar MJ, Druet P, Fournié GJ, Saoudi A, Damoiseaux J.

J Immunol. 2001 Mar 1;166(5):2944-52.

27.

Anti-SSA/Ro52 autoantibodies blocking the cardiac 5-HT4 serotoninergic receptor could explain neonatal lupus congenital heart block.

Eftekhari P, Sallé L, Lezoualc'h F, Mialet J, Gastineau M, Briand JP, Isenberg DA, Fournié GJ, Argibay J, Fischmeister R, Muller S, Hoebeke J.

Eur J Immunol. 2000 Oct;30(10):2782-90.

28.

Rat chromosome 9 bears a major susceptibility locus for IgE response.

Mas M, Subra JF, Lagrange D, Pilipenko-Appolinaire S, Kermarrec N, Gauguier D, Druet P, Fournié GJ.

Eur J Immunol. 2000 Jun;30(6):1698-705.

29.

Antigen specificity of anti-nuclear antibodies complexed to nucleosomes determines glomerular basement membrane binding in vivo.

van Bruggen MC, Walgreen B, Rijke TP, Tamboer W, Kramers K, Smeenk RJ, Monestier M, Fournie GJ, Berden JH.

Eur J Immunol. 1997 Jun;27(6):1564-9.

PMID:
9209511
30.
32.

Towards understanding the pathogenesis of SLE.

Fournié GJ, Druet P.

Nephrol Dial Transplant. 1996 Jan;11(1):10-2. No abstract available.

PMID:
8649614
33.

A chemiluminescent microplate assay to detect DNA damage induced by genotoxic treatments.

Salles B, Provot C, Calsou P, Hennebelle I, Gosset I, Fournié GJ.

Anal Biochem. 1995 Nov 20;232(1):37-42.

PMID:
8600829
34.

Study of LDL and acetylated LDL endocytosis by mononuclear cells in HIV infection.

Juompan L, Puel J, Fournié GJ, Benoist H.

Biochim Biophys Acta. 1995 Aug 15;1272(1):21-8.

35.

Evidence for a dual effect of acebutolol, a beta blocker, on the mouse humoral immune response.

In S, Le Lann AD, Fournie GJ, Benoist H.

Immunopharmacol Immunotoxicol. 1995 Aug;17(3):529-50.

PMID:
8576544
36.

Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours.

Fournié GJ, Courtin JP, Laval F, Chalé JJ, Pourrat JP, Pujazon MC, Lauque D, Carles P.

Cancer Lett. 1995 May 8;91(2):221-7.

PMID:
7767913
37.

LDL and acetyl-LDL inhibit the NK activity and are taken up by CD56+ lymphocytes.

Juompan L, Fournié GJ, Benoist H.

Biochim Biophys Acta. 1994 Oct 20;1224(1):1-10.

PMID:
7524682
38.

Urinary DNA as an indicator of nephrotoxicity caused by endotoxin and gentamicin in mice.

Le Lann AD, Bret LC, Delverdier ME, Amardeilh MF, Alary C, Fournié GJ.

Toxicology. 1994 Sep 6;92(1-3):1-10.

PMID:
7940553
39.

In vitro inhibition of natural-killer-mediated lysis by chromatin fragments.

Le Lann AD, Fournié GJ, Boissier L, Toutain PL, Benoist H.

Cancer Immunol Immunother. 1994 Sep;39(3):185-92.

PMID:
7923249
40.

Autoimmunity to histones, ubiquitin, and ubiquitinated histone H2A in NZB x NZW and MRL-lpr/lpr mice. Anti-histone antibodies are concentrated in glomerular eluates of lupus mice.

Elouaai F, Lulé J, Benoist H, Appolinaire-Pilipenko S, Atanassov C, Muller S, Fournié GJ.

Nephrol Dial Transplant. 1994;9(4):362-6.

PMID:
8084447
41.

Plasma DNA as cell death marker in elderly patients.

Fournié GJ, Martres F, Pourrat JP, Alary C, Rumeau M.

Gerontology. 1993;39(4):215-21.

PMID:
8244049
42.

Kidney tubule enzymes and extracellular DNA in urine as markers for nephrotoxicity in the guinea pig.

Bret L, Hasim M, Lefebvre H, Fournié GJ, Braun JP.

Enzyme Protein. 1993;47(1):27-36.

PMID:
7912137
43.

An in vivo model for the experimental selection of drugs able to prevent immune complex glomerulonephritis.

In S, Le Lann AD, Oksman F, Fournié EL, Labarre JF, Benoist H, Fournié GJ.

Int J Immunopharmacol. 1992 Jul;14(5):871-6.

PMID:
1387391
44.

Quantitative clonal analysis of the B cell repertoire in human lupus.

Zouali M, Fournié GJ, Thèze J.

Cell Immunol. 1991 Mar;133(1):161-77.

PMID:
1991326
45.

The beta-blocker acebutolol down modulates the spontaneous polyclonal activation of lymphocytes in NZB X NZW lupus mice.

In S, Lulé J, f1noist H, Oksman F, Appolinaire-Pilipenko S, Alary C, Rollet C, Fournié GJ.

Int J Immunopharmacol. 1991;13(5):517-24.

PMID:
1783464
46.

Treatment of end stage MRL-1pr/lpr mouse lupus disease by a cyclophosphazene derived drug and by cyclosporin A.

In S, Dueymes M, Appolinaire-Pilipenko S, Sournies F, Labarre JF, Fournié GJ.

J Clin Lab Immunol. 1990 Jun;32(2):85-90.

PMID:
1967044
47.

Quantitation of blood plasma DNA as an index of in vivo cytotoxicity.

Bret L, Lulé J, Alary C, Appolinaire-Pilipenko S, Pourrat JP, Fournié GJ.

Toxicology. 1990 Apr 30;61(3):283-92.

PMID:
2330600
48.

Extracellular DNA in blood and urine as a potential marker for cytotoxicity and nephrotoxicity in the mouse.

Bret L, Lulé J, Pourrat JP, Fournié GJ.

Ren Fail. 1990;12(3):133-9.

PMID:
2287766
49.

Polyclonal stimulation of lymphocytes induced by beta blockers in the mouse: influences of age, sex and strain.

In S, Lulé J, Fournié GJ.

Immunopharmacol Immunotoxicol. 1990;12(2):181-90.

PMID:
2229920
50.

Modulation of polyclonal activation of lymphocytes by cyclophosphazenic compounds bearing ethylene-imino groups and vectorized by polyamines.

Dueymes M, In S, Labarre JF, Sournies F, Fournié GJ.

Int J Immunopharmacol. 1990;12(5):555-60.

PMID:
2210915

Supplemental Content

Loading ...
Support Center